Quadcap Wealth Management’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-4,000
Closed -$8.88K – 440
2026
Q1
$8.88K Hold
4,000
– – ﹤0.01% 396
2025
Q4
$6.52K Hold
4,000
– – ﹤0.01% 395
2025
Q3
$5.2K Buy
+4,000
New +$3.47K ﹤0.01% 405

Other funds holding OVID

Quadcap Wealth Management's OVID Position: Q3 2026 in Review

Quadcap Wealth Management held its Ovid Therapeutics (OVID) position steady in Q3 2026 at 11,111 shares worth $27.7K. The position accounts for ﹤0.01% of the portfolio, ranked #425.

Quadcap Wealth Management first reported a position in OVID in Q3 2025 and has held it in 5 quarters since. The position peaked at $29.9K in Q2 2026. 127 funds tracked by Wall St. Rank hold OVID as of Q3 2026.

  • Quadcap Wealth Management held 11,111 shares of Ovid Therapeutics worth $27.7K as of Q3 2026.
  • Quadcap Wealth Management left its Ovid Therapeutics share count unchanged in Q3 2026.
  • Ovid Therapeutics made up ﹤0.01% of Quadcap Wealth Management's portfolio in Q3 2026, its #425 holding.
  • Quadcap Wealth Management first reported a position in Ovid Therapeutics in Q3 2025 and has held it in 5 quarters since.
  • Quadcap Wealth Management's Ovid Therapeutics position peaked at $29.9K in Q2 2026.
  • 127 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q3 2026.

Based on Quadcap Wealth Management's 13F filing for Q3 2026, filed 2 Nov 2026.